50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,647.29
DOW   29,134.99
QQQ   274.48
Layoffs Aren't the Solution to Your Profitability Crisis. Here's the Simple 4-Step Process You Should Be Following Instead.
'A Gold Storm Is Coming' (Ad)
Is There Value In These Growth Stocks?
Build A Better Tech Portfolio With Jabil Inc.
'A Gold Storm Is Coming' (Ad)
US stocks end mixed a day after Dow entered a bear market
Autodesk Is A Mature Company Still Acting Like A Growth Stock
CEO of biggest PE firm predicts “social unrest” (Ad)
Leaks on Russian gas pipelines raise concerns about sabotage
Vote in Ukraine's Russia-held areas stokes tension with West
S&P 500   3,647.29
DOW   29,134.99
QQQ   274.48
Layoffs Aren't the Solution to Your Profitability Crisis. Here's the Simple 4-Step Process You Should Be Following Instead.
'A Gold Storm Is Coming' (Ad)
Is There Value In These Growth Stocks?
Build A Better Tech Portfolio With Jabil Inc.
'A Gold Storm Is Coming' (Ad)
US stocks end mixed a day after Dow entered a bear market
Autodesk Is A Mature Company Still Acting Like A Growth Stock
CEO of biggest PE firm predicts “social unrest” (Ad)
Leaks on Russian gas pipelines raise concerns about sabotage
Vote in Ukraine's Russia-held areas stokes tension with West
S&P 500   3,647.29
DOW   29,134.99
QQQ   274.48
Layoffs Aren't the Solution to Your Profitability Crisis. Here's the Simple 4-Step Process You Should Be Following Instead.
'A Gold Storm Is Coming' (Ad)
Is There Value In These Growth Stocks?
Build A Better Tech Portfolio With Jabil Inc.
'A Gold Storm Is Coming' (Ad)
US stocks end mixed a day after Dow entered a bear market
Autodesk Is A Mature Company Still Acting Like A Growth Stock
CEO of biggest PE firm predicts “social unrest” (Ad)
Leaks on Russian gas pipelines raise concerns about sabotage
Vote in Ukraine's Russia-held areas stokes tension with West
S&P 500   3,647.29
DOW   29,134.99
QQQ   274.48
Layoffs Aren't the Solution to Your Profitability Crisis. Here's the Simple 4-Step Process You Should Be Following Instead.
'A Gold Storm Is Coming' (Ad)
Is There Value In These Growth Stocks?
Build A Better Tech Portfolio With Jabil Inc.
'A Gold Storm Is Coming' (Ad)
US stocks end mixed a day after Dow entered a bear market
Autodesk Is A Mature Company Still Acting Like A Growth Stock
CEO of biggest PE firm predicts “social unrest” (Ad)
Leaks on Russian gas pipelines raise concerns about sabotage
Vote in Ukraine's Russia-held areas stokes tension with West
CVE:NXG

NexgenRx - NXG Stock Forecast, Price & News

C$0.26
-0.03 (-8.62%)
(As of 09/27/2022 05:12 PM ET)
Add
Compare
Today's Range
C$0.27
C$0.28
50-Day Range
C$0.27
C$0.38
52-Week Range
C$0.27
C$0.46
Volume
28,300 shs
Average Volume
40,009 shs
Market Capitalization
C$18.64 million
P/E Ratio
5.30
Dividend Yield
6.90%
Price Target
N/A

About NexgenRx

NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans in Canada. It offers prescription drug claims; dental claims; and claims for extended health benefits, as well as provides a health care spending account that offers an amount of money to an individual to pay for health or dental benefits. The company also provides individual and aggregate stop loss products; medical emergency and travel assistance insurance services; administrative services, including the collection and payment of premiums for life and LTD coverage, as well as a suite of reporting tools; Web claims submission services; direct deposit services; and ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.

Receive NXG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NexgenRx and its competitors with MarketBeat's FREE daily newsletter.

NXG Stock News Headlines

Nexgenrx Announces Declaration Of Dividend
NXG.V - NexgenRx Inc. Profile | Reuters
How Is NexgenRx's (CVE:NXG) CEO Paid Relative To Peers?
NexgenRx Inc.: NexgenRx Announces 2020 Q2 Interim Results
NexgenRx Announces 2020 Q2 Interim Results
NexgenRX Inc.
NexgenRx Announces 2020 Q1 Interim Results
NexgenRx Inc.: NexgenRx Announces 2020 Q1 Interim Results
Here's What We Think About NexgenRx Inc.'s (CVE:NXG) CEO Pay
See More Headlines
Receive NXG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NexgenRx and its competitors with MarketBeat's FREE daily newsletter.

NXG Company Calendar

Today
9/28/2022
Next Earnings (Estimated)
11/17/2022

Industry, Sector and Symbol

Industry
Health Care Plans
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$12.56 million
Cash Flow
C$0.02 per share
Book Value
C$0.12 per share

Miscellaneous

Free Float
N/A
Market Cap
C$18.64 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Ronald C. Loucks B.B.A. (Age 72)
    Founder, CEO, Pres & Director
    Comp: $230k
  • Mr. Kelly Elher C.A.
    CPA, CA, CPA, Chief Financial Officer
  • Mr. Andrew Munroe
    Sr. VP of Pharma & Payor Partners
  • Mr. Jason Robinson
    Sr. VP of Admin.
  • Ms. Doreen Harvey
    Lead HR
  • Mr. Paul Anthony Bolger LL.B.
    M.B.A., Company Sec.
  • Mr. Avik Debroy
    Financial Controller













NXG Stock - Frequently Asked Questions

How have NXG shares performed in 2022?

NexgenRx's stock was trading at C$0.40 on January 1st, 2022. Since then, NXG stock has decreased by 33.8% and is now trading at C$0.27.
View the best growth stocks for 2022 here
.

When is NexgenRx's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 17th 2022.
View our NXG earnings forecast
.

Is NexgenRx a good dividend stock?

NexgenRx (CVE:NXG) pays an annual dividend of C$0.01 per share and currently has a dividend yield of 6.90%. NXG has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 10.00%. This payout ratio is at a healthy, sustainable level, below 75%.

What other stocks do shareholders of NexgenRx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NexgenRx investors own include WestJet Airlines (WJA) and Hydro One (H).

What is NexgenRx's stock symbol?

NexgenRx trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NXG."

How do I buy shares of NexgenRx?

Shares of NXG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is NexgenRx's stock price today?

One share of NXG stock can currently be purchased for approximately C$0.27.

How much money does NexgenRx make?

NexgenRx (CVE:NXG) has a market capitalization of C$18.64 million and generates C$12.56 million in revenue each year.

How can I contact NexgenRx?

NexgenRx's mailing address is 185 the West Mall Suite 600, ETOBICOKE, ON M9C 5L5, Canada. The official website for the company is www.nexgenrx.com. The company can be reached via phone at +1-416-6953393.

This page (CVE:NXG) was last updated on 9/28/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.